BioHarvest Sciences Inc.
BioHarvest Sciences Inc. (CNVCF) Stock Competitors & Peer Comparison
See (CNVCF) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| CNVCF | $6.30 | N/A | 109.2M | -5.00 | -$1.26 | N/A |
| MKGAF | $152.42 | -0.19% | 67.2B | 19.19 | $8.06 | +1.61% |
| MKKGY | $29.72 | -2.17% | 64.8B | 18.52 | $1.61 | +1.68% |
| IPSEY | $46.15 | +0.00% | 61B | 29.02 | $1.59 | +0.86% |
| TKPHF | $37.05 | +0.14% | 58.4B | 80.43 | $0.46 | +3.57% |
| HLNCF | $5.69 | +11.79% | 49.3B | 24.04 | $0.23 | +1.65% |
| SDZNY | $84.75 | -1.84% | 36.8B | 164.50 | $0.52 | +0.85% |
| TEVJF | $28.36 | +0.00% | 32.5B | 23.44 | $1.21 | N/A |
| SGIOF | $25.94 | -0.23% | 22.1B | 20.27 | $1.28 | +1.70% |
| SGIOY | $11.68 | +0.08% | 20B | 17.80 | $0.66 | +1.71% |
Stock Comparison
CNVCF vs MKGAF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, MKGAF has a market cap of 67.2B. Regarding current trading prices, CNVCF is priced at $6.30, while MKGAF trades at $152.42.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas MKGAF's P/E ratio is 19.19. In terms of profitability, CNVCF's ROE is +1.21%, compared to MKGAF's ROE of +0.10%. Regarding short-term risk, CNVCF is less volatile compared to MKGAF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check MKGAF's competition here
CNVCF vs MKKGY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, MKKGY has a market cap of 64.8B. Regarding current trading prices, CNVCF is priced at $6.30, while MKKGY trades at $29.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas MKKGY's P/E ratio is 18.52. In terms of profitability, CNVCF's ROE is +1.21%, compared to MKKGY's ROE of +0.10%. Regarding short-term risk, CNVCF is less volatile compared to MKKGY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check MKKGY's competition here
CNVCF vs IPSEY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, IPSEY has a market cap of 61B. Regarding current trading prices, CNVCF is priced at $6.30, while IPSEY trades at $46.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas IPSEY's P/E ratio is 29.02. In terms of profitability, CNVCF's ROE is +1.21%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, CNVCF and IPSEY have similar daily volatility (0.00).Check IPSEY's competition here
CNVCF vs TKPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TKPHF has a market cap of 58.4B. Regarding current trading prices, CNVCF is priced at $6.30, while TKPHF trades at $37.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TKPHF's P/E ratio is 80.43. In terms of profitability, CNVCF's ROE is +1.21%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, CNVCF is less volatile compared to TKPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check TKPHF's competition here
CNVCF vs HLNCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HLNCF has a market cap of 49.3B. Regarding current trading prices, CNVCF is priced at $6.30, while HLNCF trades at $5.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HLNCF's P/E ratio is 24.04. In terms of profitability, CNVCF's ROE is +1.21%, compared to HLNCF's ROE of +0.09%. Regarding short-term risk, CNVCF is less volatile compared to HLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check HLNCF's competition here
CNVCF vs SDZNY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SDZNY has a market cap of 36.8B. Regarding current trading prices, CNVCF is priced at $6.30, while SDZNY trades at $84.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SDZNY's P/E ratio is 164.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to SDZNY's ROE of +0.02%. Regarding short-term risk, CNVCF is less volatile compared to SDZNY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check SDZNY's competition here
CNVCF vs TEVJF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TEVJF has a market cap of 32.5B. Regarding current trading prices, CNVCF is priced at $6.30, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, CNVCF's ROE is +1.21%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, CNVCF and TEVJF have similar daily volatility (0.00).Check TEVJF's competition here
CNVCF vs SGIOF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SGIOF has a market cap of 22.1B. Regarding current trading prices, CNVCF is priced at $6.30, while SGIOF trades at $25.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SGIOF's P/E ratio is 20.27. In terms of profitability, CNVCF's ROE is +1.21%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, CNVCF is less volatile compared to SGIOF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check SGIOF's competition here
CNVCF vs SGIOY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SGIOY has a market cap of 20B. Regarding current trading prices, CNVCF is priced at $6.30, while SGIOY trades at $11.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SGIOY's P/E ratio is 17.80. In terms of profitability, CNVCF's ROE is +1.21%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, CNVCF is less volatile compared to SGIOY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check SGIOY's competition here
CNVCF vs TAIPY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, CNVCF is priced at $6.30, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, CNVCF's ROE is +1.21%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, CNVCF is less volatile compared to TAIPY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check TAIPY's competition here
CNVCF vs ESALY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, CNVCF is priced at $6.30, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ESALY's P/E ratio is 20.54. In terms of profitability, CNVCF's ROE is +1.21%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, CNVCF is less volatile compared to ESALY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check ESALY's competition here
CNVCF vs BIOVF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, BIOVF has a market cap of 12.8B. Regarding current trading prices, CNVCF is priced at $6.30, while BIOVF trades at $37.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas BIOVF's P/E ratio is 246.67. In terms of profitability, CNVCF's ROE is +1.21%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, CNVCF and BIOVF have similar daily volatility (0.00).Check BIOVF's competition here
CNVCF vs ESAIY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ESAIY has a market cap of 9.4B. Regarding current trading prices, CNVCF is priced at $6.30, while ESAIY trades at $8.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ESAIY's P/E ratio is 28.31. In terms of profitability, CNVCF's ROE is +1.21%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, CNVCF is less volatile compared to ESAIY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check ESAIY's competition here
CNVCF vs IPSEF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, CNVCF is priced at $6.30, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, CNVCF's ROE is +1.21%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, CNVCF and IPSEF have similar daily volatility (0.00).Check IPSEF's competition here
CNVCF vs ESALF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ESALF has a market cap of 9.3B. Regarding current trading prices, CNVCF is priced at $6.30, while ESALF trades at $33.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ESALF's P/E ratio is 28.70. In terms of profitability, CNVCF's ROE is +1.21%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, CNVCF and ESALF have similar daily volatility (0.00).Check ESALF's competition here
CNVCF vs SMDPY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SMDPY has a market cap of 7.2B. Regarding current trading prices, CNVCF is priced at $6.30, while SMDPY trades at $24.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SMDPY's P/E ratio is 4.32. In terms of profitability, CNVCF's ROE is +1.21%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, CNVCF is less volatile compared to SMDPY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check SMDPY's competition here
CNVCF vs SFOSF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SFOSF has a market cap of 6.9B. Regarding current trading prices, CNVCF is priced at $6.30, while SFOSF trades at $2.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SFOSF's P/E ratio is 14.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to SFOSF's ROE of +0.07%. Regarding short-term risk, CNVCF and SFOSF have similar daily volatility (0.00).Check SFOSF's competition here
CNVCF vs DNPUF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, DNPUF has a market cap of 6.5B. Regarding current trading prices, CNVCF is priced at $6.30, while DNPUF trades at $14.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas DNPUF's P/E ratio is 6.37. In terms of profitability, CNVCF's ROE is +1.21%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, CNVCF is less volatile compared to DNPUF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check DNPUF's competition here
CNVCF vs LVZPF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, CNVCF is priced at $6.30, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, CNVCF's ROE is +1.21%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, CNVCF and LVZPF have similar daily volatility (0.00).Check LVZPF's competition here
CNVCF vs GZPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GZPHF has a market cap of 5.9B. Regarding current trading prices, CNVCF is priced at $6.30, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, CNVCF and GZPHF have similar daily volatility (0.00).Check GZPHF's competition here
CNVCF vs HLUBF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HLUBF has a market cap of 5.8B. Regarding current trading prices, CNVCF is priced at $6.30, while HLUBF trades at $5.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HLUBF's P/E ratio is 11.43. In terms of profitability, CNVCF's ROE is +1.21%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, CNVCF and HLUBF have similar daily volatility (0.00).Check HLUBF's competition here
CNVCF vs HLBBF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HLBBF has a market cap of 4.8B. Regarding current trading prices, CNVCF is priced at $6.30, while HLBBF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HLBBF's P/E ratio is 11.96. In terms of profitability, CNVCF's ROE is +1.21%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, CNVCF and HLBBF have similar daily volatility (0.00).Check HLBBF's competition here
CNVCF vs HKMPY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HKMPY has a market cap of 4.8B. Regarding current trading prices, CNVCF is priced at $6.30, while HKMPY trades at $44.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HKMPY's P/E ratio is 13.10. In terms of profitability, CNVCF's ROE is +1.21%, compared to HKMPY's ROE of +0.15%. Regarding short-term risk, CNVCF and HKMPY have similar daily volatility (0.00).Check HKMPY's competition here
CNVCF vs HKMPF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HKMPF has a market cap of 4.8B. Regarding current trading prices, CNVCF is priced at $6.30, while HKMPF trades at $21.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HKMPF's P/E ratio is 13.03. In terms of profitability, CNVCF's ROE is +1.21%, compared to HKMPF's ROE of +0.15%. Regarding short-term risk, CNVCF and HKMPF have similar daily volatility (0.00).Check HKMPF's competition here
CNVCF vs SGFEF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SGFEF has a market cap of 4.6B. Regarding current trading prices, CNVCF is priced at $6.30, while SGFEF trades at $104.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SGFEF's P/E ratio is 23.51. In terms of profitability, CNVCF's ROE is +1.21%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, CNVCF and SGFEF have similar daily volatility (0.00).Check SGFEF's competition here
CNVCF vs ULIHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ULIHF has a market cap of 3.7B. Regarding current trading prices, CNVCF is priced at $6.30, while ULIHF trades at $1.88.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ULIHF's P/E ratio is 7.81. In terms of profitability, CNVCF's ROE is +1.21%, compared to ULIHF's ROE of +0.20%. Regarding short-term risk, CNVCF and ULIHF have similar daily volatility (0.00).Check ULIHF's competition here
CNVCF vs APNHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, APNHF has a market cap of 3.6B. Regarding current trading prices, CNVCF is priced at $6.30, while APNHF trades at $8.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas APNHF's P/E ratio is -54.67. In terms of profitability, CNVCF's ROE is +1.21%, compared to APNHF's ROE of -0.01%. Regarding short-term risk, CNVCF and APNHF have similar daily volatility (0.00).Check APNHF's competition here
CNVCF vs APNHY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, APNHY has a market cap of 3.5B. Regarding current trading prices, CNVCF is priced at $6.30, while APNHY trades at $8.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas APNHY's P/E ratio is -52.13. In terms of profitability, CNVCF's ROE is +1.21%, compared to APNHY's ROE of -0.01%. Regarding short-term risk, CNVCF is less volatile compared to APNHY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check APNHY's competition here
CNVCF vs LBTSF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, CNVCF is priced at $6.30, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas LBTSF's P/E ratio is 66.74. In terms of profitability, CNVCF's ROE is +1.21%, compared to LBTSF's ROE of +0.03%. Regarding short-term risk, CNVCF and LBTSF have similar daily volatility (0.00).Check LBTSF's competition here
CNVCF vs CHSYF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, CNVCF is priced at $6.30, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to CHSYF's ROE of +0.10%. Regarding short-term risk, CNVCF and CHSYF have similar daily volatility (0.00).Check CHSYF's competition here
CNVCF vs INVVY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, CNVCF is priced at $6.30, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas INVVY's P/E ratio is -62.42. In terms of profitability, CNVCF's ROE is +1.21%, compared to INVVY's ROE of -0.60%. Regarding short-term risk, CNVCF and INVVY have similar daily volatility (0.00).Check INVVY's competition here
CNVCF vs IZQVF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, CNVCF is priced at $6.30, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, CNVCF's ROE is +1.21%, compared to IZQVF's ROE of -0.60%. Regarding short-term risk, CNVCF and IZQVF have similar daily volatility (0.00).Check IZQVF's competition here
CNVCF vs HYPMY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HYPMY has a market cap of 2.8B. Regarding current trading prices, CNVCF is priced at $6.30, while HYPMY trades at $4.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HYPMY's P/E ratio is 17.60. In terms of profitability, CNVCF's ROE is +1.21%, compared to HYPMY's ROE of +0.07%. Regarding short-term risk, CNVCF is less volatile compared to HYPMY. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check HYPMY's competition here
CNVCF vs HMDCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HMDCF has a market cap of 2.6B. Regarding current trading prices, CNVCF is priced at $6.30, while HMDCF trades at $3.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HMDCF's P/E ratio is 5.70. In terms of profitability, CNVCF's ROE is +1.21%, compared to HMDCF's ROE of +0.47%. Regarding short-term risk, CNVCF and HMDCF have similar daily volatility (0.00).Check HMDCF's competition here
CNVCF vs NPPNY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, NPPNY has a market cap of 2.3B. Regarding current trading prices, CNVCF is priced at $6.30, while NPPNY trades at $8.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas NPPNY's P/E ratio is 10.78. In terms of profitability, CNVCF's ROE is +1.21%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, CNVCF and NPPNY have similar daily volatility (0.00).Check NPPNY's competition here
CNVCF vs DMPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, CNVCF is priced at $6.30, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, CNVCF's ROE is +1.21%, compared to DMPHF's ROE of +0.19%. Regarding short-term risk, CNVCF and DMPHF have similar daily volatility (0.00).Check DMPHF's competition here
CNVCF vs NPNKF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, CNVCF is priced at $6.30, while NPNKF trades at $30.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas NPNKF's P/E ratio is 9.84. In terms of profitability, CNVCF's ROE is +1.21%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, CNVCF and NPNKF have similar daily volatility (0.00).Check NPNKF's competition here
CNVCF vs HTSUF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, CNVCF is priced at $6.30, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, CNVCF's ROE is +1.21%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, CNVCF and HTSUF have similar daily volatility (0.00).Check HTSUF's competition here
CNVCF vs ARSUF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ARSUF has a market cap of 2B. Regarding current trading prices, CNVCF is priced at $6.30, while ARSUF trades at $27.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ARSUF's P/E ratio is 19.42. In terms of profitability, CNVCF's ROE is +1.21%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, CNVCF and ARSUF have similar daily volatility (0.00).Check ARSUF's competition here
CNVCF vs DUTV Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, CNVCF is priced at $6.30, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas DUTV's P/E ratio is N/A. In terms of profitability, CNVCF's ROE is +1.21%, compared to DUTV's ROE of -0.05%. Regarding short-term risk, CNVCF is less volatile compared to DUTV. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check DUTV's competition here
CNVCF vs TSMRF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, CNVCF is priced at $6.30, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, CNVCF's ROE is +1.21%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, CNVCF and TSMRF have similar daily volatility (0.00).Check TSMRF's competition here
CNVCF vs CURLF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CURLF has a market cap of 1.7B. Regarding current trading prices, CNVCF is priced at $6.30, while CURLF trades at $2.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CURLF's P/E ratio is -6.25. In terms of profitability, CNVCF's ROE is +1.21%, compared to CURLF's ROE of -0.31%. Regarding short-term risk, CNVCF is less volatile compared to CURLF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CURLF's competition here
CNVCF vs MITPF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, CNVCF is priced at $6.30, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas MITPF's P/E ratio is -10.81. In terms of profitability, CNVCF's ROE is +1.21%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, CNVCF is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check MITPF's competition here
CNVCF vs SHPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SHPHF has a market cap of 1.6B. Regarding current trading prices, CNVCF is priced at $6.30, while SHPHF trades at $0.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SHPHF's P/E ratio is -5.67. In terms of profitability, CNVCF's ROE is +1.21%, compared to SHPHF's ROE of -0.02%. Regarding short-term risk, CNVCF and SHPHF have similar daily volatility (0.00).Check SHPHF's competition here
CNVCF vs KARBF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, CNVCF is priced at $6.30, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas KARBF's P/E ratio is 262.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to KARBF's ROE of N/A. Regarding short-term risk, CNVCF and KARBF have similar daily volatility (0.00).Check KARBF's competition here
CNVCF vs GTBIF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GTBIF has a market cap of 1.5B. Regarding current trading prices, CNVCF is priced at $6.30, while GTBIF trades at $6.43.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GTBIF's P/E ratio is 38.12. In terms of profitability, CNVCF's ROE is +1.21%, compared to GTBIF's ROE of +0.02%. Regarding short-term risk, CNVCF is less volatile compared to GTBIF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check GTBIF's competition here
CNVCF vs EVOTF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, EVOTF has a market cap of 1.4B. Regarding current trading prices, CNVCF is priced at $6.30, while EVOTF trades at $8.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas EVOTF's P/E ratio is -7.42. In terms of profitability, CNVCF's ROE is +1.21%, compared to EVOTF's ROE of -0.18%. Regarding short-term risk, CNVCF and EVOTF have similar daily volatility (0.00).Check EVOTF's competition here
CNVCF vs CHIZF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, CNVCF is priced at $6.30, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, CNVCF's ROE is +1.21%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, CNVCF and CHIZF have similar daily volatility (0.00).Check CHIZF's competition here
CNVCF vs SWGHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, CNVCF is priced at $6.30, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, CNVCF's ROE is +1.21%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, CNVCF and SWGHF have similar daily volatility (0.00).Check SWGHF's competition here
CNVCF vs CASBF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, CNVCF is priced at $6.30, while CASBF trades at $3.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CASBF's P/E ratio is -37.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to CASBF's ROE of -0.03%. Regarding short-term risk, CNVCF and CASBF have similar daily volatility (0.00).Check CASBF's competition here
CNVCF vs LJUIF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, CNVCF is priced at $6.30, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, CNVCF's ROE is +1.21%, compared to LJUIF's ROE of +0.09%. Regarding short-term risk, CNVCF and LJUIF have similar daily volatility (0.00).Check LJUIF's competition here
CNVCF vs TCNNF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, CNVCF is priced at $6.30, while TCNNF trades at $6.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TCNNF's P/E ratio is -9.79. In terms of profitability, CNVCF's ROE is +1.21%, compared to TCNNF's ROE of -0.11%. Regarding short-term risk, CNVCF is less volatile compared to TCNNF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check TCNNF's competition here
CNVCF vs KSPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, CNVCF is priced at $6.30, while KSPHF trades at $26.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas KSPHF's P/E ratio is 12.04. In terms of profitability, CNVCF's ROE is +1.21%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, CNVCF and KSPHF have similar daily volatility (0.00).Check KSPHF's competition here
CNVCF vs BIOGY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, CNVCF is priced at $6.30, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, CNVCF's ROE is +1.21%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, CNVCF and BIOGY have similar daily volatility (0.00).Check BIOGY's competition here
CNVCF vs GNMLF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GNMLF has a market cap of 1B. Regarding current trading prices, CNVCF is priced at $6.30, while GNMLF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GNMLF's P/E ratio is 10.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to GNMLF's ROE of +0.13%. Regarding short-term risk, CNVCF and GNMLF have similar daily volatility (0.00).Check GNMLF's competition here
CNVCF vs KKPCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, CNVCF is priced at $6.30, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, CNVCF's ROE is +1.21%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, CNVCF and KKPCF have similar daily volatility (0.00).Check KKPCF's competition here
CNVCF vs TWAPF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, CNVCF is priced at $6.30, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, CNVCF's ROE is +1.21%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, CNVCF and TWAPF have similar daily volatility (0.00).Check TWAPF's competition here
CNVCF vs NIKA Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, NIKA has a market cap of 785.6M. Regarding current trading prices, CNVCF is priced at $6.30, while NIKA trades at $0.76.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas NIKA's P/E ratio is N/A. In terms of profitability, CNVCF's ROE is +1.21%, compared to NIKA's ROE of +0.21%. Regarding short-term risk, CNVCF and NIKA have similar daily volatility (0.00).Check NIKA's competition here
CNVCF vs CSWYF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, CNVCF is priced at $6.30, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, CNVCF's ROE is +1.21%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, CNVCF and CSWYF have similar daily volatility (0.00).Check CSWYF's competition here
CNVCF vs TRXPF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, CNVCF is priced at $6.30, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, CNVCF's ROE is +1.21%, compared to TRXPF's ROE of +0.04%. Regarding short-term risk, CNVCF and TRXPF have similar daily volatility (0.00).Check TRXPF's competition here
CNVCF vs SHEZF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SHEZF has a market cap of 690.3M. Regarding current trading prices, CNVCF is priced at $6.30, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, CNVCF's ROE is +1.21%, compared to SHEZF's ROE of +0.03%. Regarding short-term risk, CNVCF and SHEZF have similar daily volatility (0.00).Check SHEZF's competition here
CNVCF vs YIHCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, CNVCF is priced at $6.30, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, CNVCF and YIHCF have similar daily volatility (0.00).Check YIHCF's competition here
CNVCF vs AIHLF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, CNVCF is priced at $6.30, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, CNVCF's ROE is +1.21%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, CNVCF and AIHLF have similar daily volatility (0.00).Check AIHLF's competition here
CNVCF vs TRSSF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, CNVCF is priced at $6.30, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, CNVCF's ROE is +1.21%, compared to TRSSF's ROE of -0.85%. Regarding short-term risk, CNVCF is less volatile compared to TRSSF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check TRSSF's competition here
CNVCF vs GLASF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GLASF has a market cap of 588.6M. Regarding current trading prices, CNVCF is priced at $6.30, while GLASF trades at $8.18.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GLASF's P/E ratio is -36.27. In terms of profitability, CNVCF's ROE is +1.21%, compared to GLASF's ROE of -0.01%. Regarding short-term risk, CNVCF is less volatile compared to GLASF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check GLASF's competition here
CNVCF vs PKBFF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, CNVCF is priced at $6.30, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas PKBFF's P/E ratio is N/A. In terms of profitability, CNVCF's ROE is +1.21%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, CNVCF and PKBFF have similar daily volatility (0.00).Check PKBFF's competition here
CNVCF vs CCHWF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, CNVCF is priced at $6.30, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, CNVCF's ROE is +1.21%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, CNVCF is less volatile compared to CCHWF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CCHWF's competition here
CNVCF vs BOIRF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, CNVCF is priced at $6.30, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, CNVCF's ROE is +1.21%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, CNVCF and BOIRF have similar daily volatility (0.00).Check BOIRF's competition here
CNVCF vs AGYTF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, AGYTF has a market cap of 504.6M. Regarding current trading prices, CNVCF is priced at $6.30, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to AGYTF's ROE of +1.75%. Regarding short-term risk, CNVCF and AGYTF have similar daily volatility (0.00).Check AGYTF's competition here
CNVCF vs KHTRF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, KHTRF has a market cap of 474.3M. Regarding current trading prices, CNVCF is priced at $6.30, while KHTRF trades at $4.60.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas KHTRF's P/E ratio is -157.42. In terms of profitability, CNVCF's ROE is +1.21%, compared to KHTRF's ROE of -0.00%. Regarding short-term risk, CNVCF and KHTRF have similar daily volatility (0.00).Check KHTRF's competition here
CNVCF vs PEXXF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, CNVCF is priced at $6.30, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to PEXXF's ROE of N/A. Regarding short-term risk, CNVCF and PEXXF have similar daily volatility (0.00).Check PEXXF's competition here
CNVCF vs SWDCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SWDCF has a market cap of 443.7M. Regarding current trading prices, CNVCF is priced at $6.30, while SWDCF trades at $2.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SWDCF's P/E ratio is 69.40. In terms of profitability, CNVCF's ROE is +1.21%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, CNVCF and SWDCF have similar daily volatility (0.00).Check SWDCF's competition here
CNVCF vs HUMDF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HUMDF has a market cap of 405.4M. Regarding current trading prices, CNVCF is priced at $6.30, while HUMDF trades at $0.41.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HUMDF's P/E ratio is 2.74. In terms of profitability, CNVCF's ROE is +1.21%, compared to HUMDF's ROE of +2.33%. Regarding short-term risk, CNVCF and HUMDF have similar daily volatility (0.00).Check HUMDF's competition here
CNVCF vs ELTP Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ELTP has a market cap of 396.6M. Regarding current trading prices, CNVCF is priced at $6.30, while ELTP trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ELTP's P/E ratio is 18.46. In terms of profitability, CNVCF's ROE is +1.21%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, CNVCF is less volatile compared to ELTP. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check ELTP's competition here
CNVCF vs VRNOF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, VRNOF has a market cap of 358.2M. Regarding current trading prices, CNVCF is priced at $6.30, while VRNOF trades at $0.99.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas VRNOF's P/E ratio is -1.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to VRNOF's ROE of -0.52%. Regarding short-term risk, CNVCF is less volatile compared to VRNOF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check VRNOF's competition here
CNVCF vs CRLBF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CRLBF has a market cap of 337.5M. Regarding current trading prices, CNVCF is priced at $6.30, while CRLBF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CRLBF's P/E ratio is -6.20. In terms of profitability, CNVCF's ROE is +1.21%, compared to CRLBF's ROE of -0.12%. Regarding short-term risk, CNVCF is less volatile compared to CRLBF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CRLBF's competition here
CNVCF vs CPHRF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CPHRF has a market cap of 284.4M. Regarding current trading prices, CNVCF is priced at $6.30, while CPHRF trades at $11.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CPHRF's P/E ratio is 16.73. In terms of profitability, CNVCF's ROE is +1.21%, compared to CPHRF's ROE of +0.16%. Regarding short-term risk, CNVCF is less volatile compared to CPHRF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CPHRF's competition here
CNVCF vs BHCCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, CNVCF is priced at $6.30, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, CNVCF's ROE is +1.21%, compared to BHCCF's ROE of +0.23%. Regarding short-term risk, CNVCF and BHCCF have similar daily volatility (0.00).Check BHCCF's competition here
CNVCF vs PLNHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, CNVCF is priced at $6.30, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, CNVCF's ROE is +1.21%, compared to PLNHF's ROE of -0.94%. Regarding short-term risk, CNVCF is less volatile compared to PLNHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check PLNHF's competition here
CNVCF vs PHCUF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, PHCUF has a market cap of 186.2M. Regarding current trading prices, CNVCF is priced at $6.30, while PHCUF trades at $7.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas PHCUF's P/E ratio is 700.00. In terms of profitability, CNVCF's ROE is +1.21%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, CNVCF and PHCUF have similar daily volatility (0.00).Check PHCUF's competition here
CNVCF vs SHIEF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, SHIEF has a market cap of 150.9M. Regarding current trading prices, CNVCF is priced at $6.30, while SHIEF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas SHIEF's P/E ratio is -7.06. In terms of profitability, CNVCF's ROE is +1.21%, compared to SHIEF's ROE of +1.40%. Regarding short-term risk, CNVCF and SHIEF have similar daily volatility (0.00).Check SHIEF's competition here
CNVCF vs COPHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, CNVCF is priced at $6.30, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas COPHF's P/E ratio is -0.02. In terms of profitability, CNVCF's ROE is +1.21%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, CNVCF is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check COPHF's competition here
CNVCF vs LOVFF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, LOVFF has a market cap of 127.4M. Regarding current trading prices, CNVCF is priced at $6.30, while LOVFF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas LOVFF's P/E ratio is 14.78. In terms of profitability, CNVCF's ROE is +1.21%, compared to LOVFF's ROE of +0.12%. Regarding short-term risk, CNVCF is less volatile compared to LOVFF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check LOVFF's competition here
CNVCF vs NWPN Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, CNVCF is priced at $6.30, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas NWPN's P/E ratio is -0.04. In terms of profitability, CNVCF's ROE is +1.21%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, CNVCF is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check NWPN's competition here
CNVCF vs BIOYF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, BIOYF has a market cap of 120.4M. Regarding current trading prices, CNVCF is priced at $6.30, while BIOYF trades at $10.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas BIOYF's P/E ratio is 19.44. In terms of profitability, CNVCF's ROE is +1.21%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, CNVCF and BIOYF have similar daily volatility (0.00).Check BIOYF's competition here
CNVCF vs CBWTF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CBWTF has a market cap of 119.3M. Regarding current trading prices, CNVCF is priced at $6.30, while CBWTF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CBWTF's P/E ratio is 2.95. In terms of profitability, CNVCF's ROE is +1.21%, compared to CBWTF's ROE of +0.29%. Regarding short-term risk, CNVCF is less volatile compared to CBWTF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CBWTF's competition here
CNVCF vs LPCUF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, CNVCF is priced at $6.30, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, CNVCF's ROE is +1.21%, compared to LPCUF's ROE of +0.04%. Regarding short-term risk, CNVCF and LPCUF have similar daily volatility (0.00).Check LPCUF's competition here
CNVCF vs ORXOF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ORXOF has a market cap of 111.5M. Regarding current trading prices, CNVCF is priced at $6.30, while ORXOF trades at $3.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ORXOF's P/E ratio is -2.48. In terms of profitability, CNVCF's ROE is +1.21%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, CNVCF and ORXOF have similar daily volatility (0.00).Check ORXOF's competition here
CNVCF vs HLTRF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, HLTRF has a market cap of 105.1M. Regarding current trading prices, CNVCF is priced at $6.30, while HLTRF trades at $3.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas HLTRF's P/E ratio is -7.47. In terms of profitability, CNVCF's ROE is +1.21%, compared to HLTRF's ROE of -0.21%. Regarding short-term risk, CNVCF and HLTRF have similar daily volatility (0.00).Check HLTRF's competition here
CNVCF vs ORXOY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ORXOY has a market cap of 102.7M. Regarding current trading prices, CNVCF is priced at $6.30, while ORXOY trades at $2.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ORXOY's P/E ratio is -2.28. In terms of profitability, CNVCF's ROE is +1.21%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, CNVCF and ORXOY have similar daily volatility (0.00).Check ORXOY's competition here
CNVCF vs AAWH Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, AAWH has a market cap of 101.6M. Regarding current trading prices, CNVCF is priced at $6.30, while AAWH trades at $0.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas AAWH's P/E ratio is -1.19. In terms of profitability, CNVCF's ROE is +1.21%, compared to AAWH's ROE of -2.27%. Regarding short-term risk, CNVCF is less volatile compared to AAWH. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check AAWH's competition here
CNVCF vs JUSHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, JUSHF has a market cap of 100.3M. Regarding current trading prices, CNVCF is priced at $6.30, while JUSHF trades at $0.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas JUSHF's P/E ratio is -1.55. In terms of profitability, CNVCF's ROE is +1.21%, compared to JUSHF's ROE of +0.89%. Regarding short-term risk, CNVCF is less volatile compared to JUSHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check JUSHF's competition here
CNVCF vs ABSCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, ABSCF has a market cap of 96M. Regarding current trading prices, CNVCF is priced at $6.30, while ABSCF trades at $1.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, CNVCF's ROE is +1.21%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, CNVCF and ABSCF have similar daily volatility (0.00).Check ABSCF's competition here
CNVCF vs CWBHF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, CWBHF has a market cap of 95.7M. Regarding current trading prices, CNVCF is priced at $6.30, while CWBHF trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas CWBHF's P/E ratio is -4.29. In terms of profitability, CNVCF's ROE is +1.21%, compared to CWBHF's ROE of -1.20%. Regarding short-term risk, CNVCF is less volatile compared to CWBHF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check CWBHF's competition here
CNVCF vs GRUSF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GRUSF has a market cap of 90.2M. Regarding current trading prices, CNVCF is priced at $6.30, while GRUSF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GRUSF's P/E ratio is 12.05. In terms of profitability, CNVCF's ROE is +1.21%, compared to GRUSF's ROE of +0.28%. Regarding short-term risk, CNVCF is less volatile compared to GRUSF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check GRUSF's competition here
CNVCF vs EOFBY Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, CNVCF is priced at $6.30, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, CNVCF's ROE is +1.21%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, CNVCF and EOFBY have similar daily volatility (0.00).Check EOFBY's competition here
CNVCF vs MEDXF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, MEDXF has a market cap of 66.7M. Regarding current trading prices, CNVCF is priced at $6.30, while MEDXF trades at $2.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas MEDXF's P/E ratio is -102.90. In terms of profitability, CNVCF's ROE is +1.21%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, CNVCF is less volatile compared to MEDXF. This indicates potentially lower risk in terms of short-term price fluctuations for CNVCF.Check MEDXF's competition here
CNVCF vs GDNSF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, CNVCF is priced at $6.30, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, CNVCF's ROE is +1.21%, compared to GDNSF's ROE of -0.24%. Regarding short-term risk, CNVCF and GDNSF have similar daily volatility (0.00).Check GDNSF's competition here
CNVCF vs PROCF Comparison February 2026
CNVCF plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, CNVCF stands at 109.2M. In comparison, PROCF has a market cap of 55.8M. Regarding current trading prices, CNVCF is priced at $6.30, while PROCF trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
CNVCF currently has a P/E ratio of -5.00, whereas PROCF's P/E ratio is 0.06. In terms of profitability, CNVCF's ROE is +1.21%, compared to PROCF's ROE of -2.24%. Regarding short-term risk, CNVCF and PROCF have similar daily volatility (0.00).Check PROCF's competition here